BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/30/2024 3:48:47 AM | Browse: 398 | Download: 1194
 |
Received |
|
2024-02-05 09:29 |
|
Peer-Review Started |
|
2024-02-05 09:29 |
|
First Decision by Editorial Office Director |
|
2024-04-10 21:16 |
|
Return for Revision |
|
2024-04-10 23:27 |
|
Revised |
|
2024-04-26 07:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-09-30 06:59 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-08 08:43 |
|
Articles in Press |
|
2024-10-08 08:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-23 10:58 |
|
Publish the Manuscript Online |
|
2024-11-30 03:48 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhi-Min Lin, Han-Yuan Gao, Shu-Han Shi and Yue-Ting Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yue-Ting Li, FAASLD, BSc, MD, Academic Editor, Department of Nephrology, The Second Affiliated Hospital of Fujian Medical University, No. 34 Zhongshan North Road, Licheng District, Quanzhou 362000, Fujian Province, China. yuetingli20230125@163.com |
| Key Words |
Mizagliflozin; Sodium-glucose cotransport protein 1; Diabetic nephropathy; Mesangial cells |
| Core Tip |
Diabetic nephropathy is a common and serious complication of diabetes, characterized by the accumulation of extracellular matrix in the renal units. Mizagliflozin can improve diabetic nephropathy impairment by inhibiting neural sodium-glucose cotransport protein 1, inflammation, and oxidative stress. Its functions are regarded as positive regulators of inflammation and oxidative stress. These findings offer new treatment methods targeting sodium-glucose cotransport protein 1 inhibitors for diabetic kidney disease. |
| Publish Date |
2024-11-30 03:48 |
| Citation |
Lin ZM, Gao HY, Shi SH, Li YT. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. World J Diabetes 2025; 16(1): 92711
|
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i1/92711.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i1.92711 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
